RecallHawk

SUCCINYLCHOLINE CHLORIDE

MANKIND PHARMA

Summary

FDA approved SUCCINYLCHOLINE CHLORIDE by MANKIND PHARMA. ANDA (Generic) approval on 2023-02-02. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

ANDA216127-1

Action Date

2023-02-02

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

SUCCINYLCHOLINE CHLORIDE, INJECTABLE, INJECTION. Application: ANDA216127

Context & Analysis

MANKIND PHARMA has 23 FDA actions in our database.

Frequently Asked Questions

How often does MANKIND PHARMA have FDA actions?

MANKIND PHARMA has 23 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA216127-1" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions